Friday, February 02, 2024 9:36:03 PM
Atlanta told me to sell last year before the price dropped for no company related reasons
What negative news came out that justified Sintx price and marketcap drop last year before the filing of the S-1? Is that all you got, that they had to raise funds? So did hundreds of other companies im sure. Tesla raised a ton of times while operating for losses for years before success. So did Amylin. This is normal for companies that are in the development stage. Raising funds, by itself, does not negate a companies marketcap.
Sintx did sell a portion of the company in 2018 so i was not incorrect in saying they were getting ready to sell. Yes it did not occur with Zimmer Biomet nor did it involve the whole company. However that does not mean it will not eventually happen in some form. I also do not believe i was incorrect in my assessment that Sintx is tied to Zimmer Biomet.
Yes or No answers on these questions please:
Is Zimmer Biomet a stakeholder, in that theyve shared scientific research, in Sintx or not?
Do you think Zimmer is the reason Sonny joined the board of Sintx and eventually became CEO?
Did Zimmer Biomet not hire Dr. Saurabh Lal, PHD?
Is Dr Lal not an expert on Si3n4 coatings and doing research for Zimmer Biomet on anti-infective technologies?
Did Zimmer Biomet acquire Implex in 2003 for 108m upfront and another 125m or so over the next two years?
Does Sintx IP not have similar use cases to Implex and therefore is the IP not worth the same or more in those use cases?
Does Sintx IP not have alot more use cases than Implex's IP did?
Did Medtronic acquire Spinal Dynamics in 2002 or 03 for 280m or so? Can Sintx IP not be used for spinal implants as well?
Do funds not naked short every offering here?
Does naked shorting not suppress stockprice and valuations?
========================================
Joe,
No, i do not behave like a stock pumper especially as i have no problem exploring negative side as well as the positive side. I think a better classification is board guru. Thats not because i know the most, as thats hardly the case, its because i share the most information with supporting evidence. I think a big difference between a board guru and pumpers/bashers is pumpers/bashers use, for example, 10% fact 90% suggestion.
PUMPERS DO THE FOLLOWING: 1. Be anonymous 2. Use 10% fact. 90% suggestion. The facts will lend credibility to your suggestions. 3. Let others help you learn about the stock. Build rapport and a support base before initiating your pumping routine. 4. Enter w/ humor and reply to all who reply to you. 5. Use multiple ISP's, handles and aliases. 6. Use two (2) or more aliases to simulate a discussion. 7. Do not start with an all out pump of the stock. Build to it. 8. Identify your foes (bashers) and the boards "guru" Use them to your advantage. Lead them do not follow their lead.
However, I explore all aspects of Sintx and will engage in discussion about the negative aspects as well as the positives. Your statement that Sonny is a lousy public company CEO is something we have discussed before. At first you claimed Sonny was a lousy CEO and as we discussed things you reduced it to lousy public CEO. I give you that. I do not disagree that Sonny operates Sintx more like a private company and so from that perspective hes a lousy public CEO.
SINT is supposed to be a reflection of Sintx. As Sintx performs well or poorly, SINT is supposed reflect that in kind. However, as ive argued, again with evidence, SINT does not accurately reflect Sintx value. Thus i treat them as two separate parts to be evaluated separately. When you do this it becomes more obvious the disconnect between them.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:05:43 PM
- SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies • GlobeNewswire Inc. • 11/13/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:17:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2025 01:00:06 PM
- SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System • GlobeNewswire Inc. • 11/03/2025 01:00:00 PM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
